Wei-De Zhong (Weide Zhong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Disease markers

Cell death & disease

Nature communications

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjie Xie, Yixun Zhang, Qianfeng Xu, Guowei Zhong, Jundong Lin, Huichan He, Qiuling Du, Huijing Tan, Muqi Chen, Zhenjie Wu, Yulin Deng, Zhaodong Han, Jianming Lu, Jianheng Ye, Fen Zou, Yangjia Zhuo, Wei-De Zhong
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy. International journal of nanomedicine 19 (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Wenjie Xie, Yixun Zhang, Qianfeng Xu, Guowei Zhong, Jundong Lin, Huichan He, Qiuling Du, Huijing Tan, Muqi Chen, Zhenjie Wu, Yulin Deng, Zhaodong Han, Jianming Lu, Jianheng Ye, Fen Zou, Yangjia Zhuo, Wei-De Zhong
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy. International journal of nanomedicine 19 (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Jia-Zheng Cao, Yu-Hang Chen, Yi-Hui Pan, Bing Liao, Yun Cao, Xin-Ke Zhang, Hui Han, Fang-Jian Zhou, Ran-Yi Liu, Wen-Fang Chen, Ze-Ying Jiang, Zi-Hao Feng, Fu-Neng Jiang, Yan-Fei Yu, Sheng-Wei Xiong, Guan-Peng Han, Qi Tang, Kui Ouyang, Gui-Mei Qu, Ji-Tao Wu, Ming Cao, Bai-Jun Dong, Yi-Ran Huang, Jin Zhang, Cai-Xia Li, Pei-Xing Li, Wei Chen, Wei-De Zhong, Jian-Ping Guo, Zhi-Ping Liu, Jer-Tsong Hsieh, Dan Xie, Mu-Yan Cai, Wei Xue, Jin-Huan Wei, Junghang Luo
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nature communications 15 (1) (2024)
Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Wei-De Zhong
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell death & disease 15 (1) (2024)
Maozhang Li, Guangwei Bai, Yi Cen, Qitong Xie, Jiahong Chen, Jia Chen, Qingbiao Chen, Wei-De Zhong, Xiaobo Zhou
Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway. Journal of translational medicine 21 (1) (2023)
Yongkang Ye, Ru-Jun Mo, Ruinian Zheng, Jun Zou, Shaoqian Liu, Qiwu Mi, Wei-De Zhong
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. Disease markers 2023 (2023)
Yongkang Ye, Ru-Jun Mo, Ruinian Zheng, Jun Zou, Shaoqian Liu, Qiwu Mi, Wei-De Zhong
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. Disease markers 2023 (2023)
Yongkang Ye, Ru-Jun Mo, Ruinian Zheng, Jun Zou, Shaoqian Liu, Qiwu Mi, Wei-De Zhong
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. Disease markers 2023 (2023)
Guian Zhang, Yong Luo, Weimin Dong, Wei-De Zhong
Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer. Computational and mathematical methods in medicine 2022 (2022)
Yan Wang, Shiyong Luo, Yuxuan Wang, Shengbang Yang, Zhitong Huang, Xue-Jin Zhu, Shanghua Cai, Qifeng Guo, Wei-De Zhong, Sihong Liu
EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway. Oxidative medicine and cellular longevity 2022 (2022)
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer. Disease markers 2022 (2022)
Jundong Lin, Huikang Yang, Yixun Zhang, Fen Zou, Huichan He, Wenjie Xie, Zhihao Zou, Ren Liu, Qianfeng Xu, Jie Zhang, Guowei Zhong, Yuejiao Li, ZhenFeng Tang, Yulin Deng, Shanghua Cai, Linyao Wang, Yugang Huang, Yangjia Zhuo, Xinqing Jiang, Wei-De Zhong
Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis. Small (Weinheim an der Bergstrasse, Germany) (2022)
Qingling Xie, Ren Liu, Zhihao Zou, Yuanfa Feng, Yiqiao Huang, Guibin Xu, Wei Sun, Yuxiang Liang, Wei-De Zhong
MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N-cadherin pathway. FEBS open bio 12 (11) (2022)
Shuai Yang, Han Guan, Zhijun Chen, Sheng Wang, Hongliang Wu, Wei-De Zhong
Analysis of the Role of Comprehensive Treatment Model in the Treatment of Prostate Cancer. Computational and mathematical methods in medicine 2022 (2022)
Hai-Bo Zhao, Yan-Ru Zeng, Zhao-Dong Han, Yang-Jia Zhuo, Ying-Ke Liang, Chi Tin Hon, Song Wan, Shulin Wu, Douglas Dahl, Wei-De Zhong, Chin-Lee Wu
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma. Cancer science 112 (10) (2021)
Qiwen Kuang, Yuxiang Liang, Yangjia Zhuo, Zhiduan Cai, Funeng Jiang, Jianjiang Xie, Yu Zheng, Wei-De Zhong
The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation. OncoTargets and therapy 14 (2021)
Ren Liu, Yuanfa Feng, Yulin Deng, Zhihao Zou, Jianheng Ye, Zhiduan Cai, Xuejin Zhu, Yingke Liang, Jianming Lu, Hui Zhang, Yong Luo, Zhaodong Han, Yangjia Zhuo, Qingling Xie, Chi Tin Hon, Yuxiang Liang, Chin-Lee Wu, Wei-De Zhong
A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yu Zheng, Sharron X Lin, Shulin Wu, Douglas M Dahl, Michael L Blute, Wei-De Zhong, Xing Zhou, Chin-Lee Wu
Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis. Cancer medicine 9 (18) (2020)
Weimin Dong, Yong Luo, Guian Zhang, Hui Zhang, Yuxiang Liang, Yangjia Zhuo, Yingke Liang, Fen Zou, Wei-De Zhong
Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer. International journal of nanomedicine 15 (2020)
Zhiduan Cai, Yulin Deng, Jianheng Ye, Yangjia Zhuo, Zezhen Liu, Yingke Liang, Hui Zhang, Xuejin Zhu, Yong Luo, Yuanfa Feng, Ren Liu, Guo Chen, Yongding Wu, Zhaodong Han, Yuxiang Liang, Funeng Jiang, Wei-De Zhong
Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer. Cancer management and research 12 (2020)
Ru-Jun Mo, Zhao-Dong Han, Ying-Ke Liang, Jian-Heng Ye, Shu-Lin Wu, Sharron X Lin, Yan-Qiong Zhang, Sheng-Da Song, Fu-Neng Jiang, Wei-De Zhong, Chin-Lee Wu
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer. International journal of cancer 144 (12) (2019)
Ying-Ke Liang, Zhao-Dong Han, Jian-Ming Lu, Ze-Zhen Liu, Yang-Jia Zhuo, Xue-Jin Zhu, Jun-Xu Chen, Jian-Heng Ye, Yu-Xiang Liang, Hui-Chan He, Wei-De Zhong
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer. Journal of cellular biochemistry 119 (9) (2018)

Wei-De Zhong.css-eqlu8i{font-size:small;padding-left:4px;} (Weide Zhong)

Publication Activity (10 Years)

Top Topics

Top Venues

Wei-De Zhong (Weide Zhong)